Ardelyx reaffirms 2026 IBSRELA $350M-$370M guidance while targeting profitability in 2027

• “In the third quarter generated over $125 million in revenue, up 19% from a year ago,” said President, CEO & Director Michael Raab, adding that management’s priorities are “accelerating the growth of IBSRELA, maintaining XPHOZAH's momentum, building and expanding our pipeline and

Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.